Company profile
Ticker
ARAY
Exchange
Website
CEO
Ms. Suzanne Winter M.B.A.
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Ares Capital • Becton, Dickinson and • Stryker • Boston Scientific • Solventum • Baxter International • Teleflex • Hercules Capital • ResMed ...
Former names
KENTEX PETROLEUM INC
SEC CIK
Corporate docs
Subsidiaries
Accuray International SARL • Accuray Europe SAS • Accuray UK, Ltd. • Accuray Asia Ltd. • Accuray Japan K.K. • Accuray Korea Limited Company • Accuray Medical Equipment (India) Private Limited • Accuray Medical Equipment (Rus) LLC. • Accuray Medical Equipment GmbH • Accuray Medical Equipment (Canada) Ltd. ...
IRS number
770268932
ARAY stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
7 Feb 25
10-Q
2025 Q2
Quarterly report
5 Feb 25
8-K
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance
5 Feb 25
8-K
Regulation FD Disclosure
21 Jan 25
8-K
Departure of Directors or Certain Officers
11 Dec 24
S-8
Registration of securities for employees
26 Nov 24
8-K
Departure of Directors or Certain Officers
25 Nov 24
10-Q
2024 Q1
Quarterly report
6 Nov 24
8-K
Accuray Reports Fiscal 2025 First Quarter Financial Results
6 Nov 24
8-K
Accuray Appoints Michael Murphy as VP, Corporate Controller
21 Oct 24
Transcripts
ARAY
Earnings call transcript
2025 Q2
5 Feb 25
ARAY
Earnings call transcript
2025 Q1
6 Nov 24
ARAY
Earnings call transcript
2024 Q4
14 Aug 24
ARAY
Earnings call transcript
2024 Q3
1 May 24
ARAY
Earnings call transcript
2024 Q2
31 Jan 24
ARAY
Earnings call transcript
2024 Q1
7 Nov 23
ARAY
Earnings call transcript
2023 Q4
9 Aug 23
ARAY
Earnings call transcript
2023 Q2
9 Aug 23
ARAY
Earnings call transcript
2023 Q3
26 Apr 23
ARAY
Earnings call transcript
2023 Q2
1 Feb 23
Latest ownership filings
Financial summary
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q | |
Cash on hand (at last report) | 65.39 mm | 65.39 mm | 65.39 mm | 65.39 mm | 65.39 mm | 65.39 mm |
Cash burn (monthly) | (no burn) | 758.67 k | (no burn) | (no burn) | (no burn) | 309.42 k |
Cash used (since last report) | n/a | 1.26 mm | n/a | n/a | n/a | 514.05 k |
Cash remaining | n/a | 64.13 mm | n/a | n/a | n/a | 64.87 mm |
Runway (months of cash) | n/a | 84.5 | n/a | n/a | n/a | 209.7 |
Institutional ownership, Q3 2024
53.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 127 |
Opened positions | 127 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 97.78 bn |
Total shares | 55.27 mm |
Total puts | 12.80 k |
Total calls | 26.20 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 8.44 mm | $15.20 bn |
Neuberger Berman | 5.64 mm | $10.14 bn |
Vanguard | 5.35 mm | $9.62 bn |
Heartland Advisors | 3.35 mm | $6.03 bn |
Renaissance Technologies | 2.79 mm | $5.02 bn |
Foundry Partners | 2.19 mm | $3.94 bn |
Geode Capital Management | 2.18 mm | $3.92 bn |
STT State Street | 1.89 mm | $3.41 bn |
Royce & Associates | 1.88 mm | $3.39 bn |
Harbert Fund Advisors | 1.85 mm | $3.33 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec 24 | Ali Pervaiz | Common Stock | Payment of exercise | Dispose F | No | No | 1.98 | 2,013 | 3.99 k | 362,231 |
2 Dec 24 | Jesse Chew | Common Stock | Payment of exercise | Dispose F | No | No | 2.15 | 42,265 | 90.87 k | 326,824 |
29 Nov 24 | Mika Nishimura | RSU Common Stock | Grant | Acquire A | No | No | 0 | 56,603 | 0.00 | 56,603 |
29 Nov 24 | Jesse Chew | RSU Common Stock | Grant | Acquire A | No | No | 0 | 187,500 | 0.00 | 187,500 |
Press releases
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance
1w ago
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
3w ago
Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025
3w ago
Leonel Peralta to Join Accuray as Chief Operations Officer
4w ago
Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System
1mo ago